From: Cell therapies for autism spectrum disorder: a systematic review of clinical applications
 | Chez et al. [15] | Dawson et al. [20] | Dawson et al. [21] | Simhal et al. [81] |
---|---|---|---|---|
CGI-I | No change | Improved significantly | Improveda | No change |
CGI-S | No change | Improved significantly | No change | - |
EOWPVT | No change | Improved significantly | No change | No change |
ROWPVT | No change | Improved significantly | - | - |
VABS | No change | Improved significantly | Improved | No change |
PDDBI | - | - | No change | No change |
Daily skills, learning capacity | No change | Improved significantly | - | No change |
Social interaction | No change | Improved significantly | No change | No change |
Adaptive behavior | No change | Improved significantly | - | No change |
Verbal cognitive ability | No change | Improved significantly | - | No change |
Brain network reconfiguration | - | - | Significant changeb | Significant changeb |
Major adverse events | None | None | None | - |